Abstract
Mice were given flurazepam, 40 mg k−1, IP, once daily for 7 consecutive days. Twenty-four and forty-eight hours after the last injection measurements were made of the effects on convulsion threshold, body temperature and locomotor activity, of drugs acting on the GABA receptor complex. Significant decreases were seen in the hypothermic and hypomobility effects of progabide at 48 h, but no significant changes were seen in the effects of pentylenetetrazol or pentobarbitone. The actions of picrotoxin in all three types of test and the convulsant action of bicuculline (IP) were significantly decreased at 24 h but not at 48 h. The convulsive, but not the hypothermic, effects of picrotoxin were increased at the 48 h interval. These results may suggest that the chronic benzodiazepine treatment decreased some aspects of GABA receptor function at 48 h after the last dose; however, such an effect probably does not explain the previously reported increases in the effects of inverse agonists following chronic agonist treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartholini G, Scatton B, Zivkovic B, Lloyd KG (1979) On the mode of action of SL 76002 a new receptor agonist. In: Krogsgaard Larsen P, Scheel-Krüger J, Kofold H (eds) GABA-neurotransmission. Munksgaard, Copenhagen, p 226
Braestrup C, Nielsen M, Squires RF (1979) No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam. Life Sci 24:347–350
File SE (1981) Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology 73:240–245
Gallagher DW, Lakoski JM, Gonsalves SF, Rauch SL (1984) Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 308:74–77
Gent JP, Haigh JRM (1983) Development of tolerance to the anticonvulsant effects of clobazam. Eur J Pharmacol 94:155–158
Goldring JM, Blaustein MP (1980) Barbiturates: physiological effects II. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic drugs, mechanisms of action. Adv Neurol 27. Raven Press, New York, pp 523–532
Gonzalez JP, McCulloch AJ, Nicholls PJ, Sewell RDE, Tekle A (1984) Subacute benzodiazepine treatment: observations on behavioral tolerance and withdrawal. Alcohol and Alcoholism 19:325–332
Gross GJ, Woodbury DM (1972) Effects of pentylenetetrazol on ion transport in the isolated toad bladder. J Pharmacol Exp Ther 81:257–272
Kaneko T, Ono H, Fukuda H (1981) Decrease in effects of muscimol on the dorsal root after repeated administration of diazepam in rats. J Pharm Dyn 4:947–951
Little HJ, Nutt DJ, Taylor SC (1984) Selective potentiation of a benzodiazepine contragonist after flurazepam treatment in mice. Br J Pharmacol 3:360P
Little HJ, Nutt DJ, Taylor SC (1986) Does chronic benzodiazepine administration cause a “withdrawal shift” across the whole benzodiazepine ligand spectrum? Br J Pharmacol 89:796P
Little HJ, Taylor SC, Nutt DJ (1987a) Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Res Bull 19:371–378
Little HJ, Nutt DJ, Taylor SC (1987b) Kindling and withdrawal changes at the benzodiazepine receptor. J Psychopharm 1:35–46
Maksay G, Ticku MD (1985) Dissociation of [35S]t-butylbicyclophosphorothionate binding differentiates convulsant and depressant drugs that modulate GABAergic transmission. J Neurochem 44:480–486
Nutt DJ (1986) Benzodiazepine dependence in the clinic: reason for anxiety? TIPS 7:457–460
Nutt DJ, Taylor SC, Little HJ (1986) Optimising the pentylenetetrazol infusion test for seizure threshold measurement. J Pharm Pharmacol 38:697–698
Olsen RW (1982) Drug interactions at the GABA receptor ionophore complex. Annu Rev Pharmacol Toxicol 22:245–277
Olsen RW, Leeb-Lundberg F (1981) Convulsant and anticonvulsant drug binding sites related to the GABA receptor/ionophore system. In: Morselli PL, Lloyd KG (eds) Workshop on neurotransmitters in epilepsy. Raven Press, New York, pp 151–163
Ramanjaneyulu R, Ticku MD (1984) Interactions of pentylene-methylenetetrazol and tetrazol analogues with the picrotoxin site of the benzodiazepine GABA receptor-ionophore complex. Eur J Pharmacol 98:337–345
Rosenberg JH, Smith S, Chiu TH (1983) Benzodiazepine-specific and nonspecific tolerance following chronic flurazepam treatment. Life Sci 32:279–285
Scherkl R, Scheuler W, Frey HH (1985) Anticonvulsant effect of clobazam in the dog: development of tolerance and physical dependence. Arch Int Pharmacodyn Ther 278:249–260
Simmonds MA (1981) Distinction between the effects of barbiturates, benzodiazepines and phenytoin on responses to gamma-amino butyric acid receptor activation and antagonism by bicuculline and picrotoxin. Br J Pharmacol 73:739–747
Simmonds MA (1982) Classification of some GABA antagonists with regard to site of action and potency in slices of rat cuneate nucleus. Eur J Pharmacol 80:347–358
Squires RF, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266:732–734
Stephens DN, Schneider HH (1985) Tolerance to the benzodiazepine diazepam in an animal model of anxety. Psychopharmacology 87:322–327
Taylor SC, Little HJ, Nutt DJ, Sellars N (1985) A benzodiazepine agonist and contragonist have hypothermic effects in rodents. Neuropharmacology 24:69–73
Ticku JK, Olsen RW (1978) Interaction of barbiturates with dihydropicrotoxin binding sites related to the GABA receptor-ionophore system. Life Sci 22:1643–1651
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nutt, D.J., Taylor, S.C., Little, H.J. et al. Changes in benzodiazepine/GABA receptor complex function in benzodiazepine-tolerant mice. Psychopharmacology 95, 407–412 (1988). https://doi.org/10.1007/BF00181957
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00181957